We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.72B
AUM Growth
+$198M
Cap. Flow
+$102M
Cap. Flow %
2.15%
Top 10 Hldgs %
9.82%
Holding
594
New
39
Increased
251
Reduced
219
Closed
63

Top Sells

Rank Stock Value
1
G icon
Genpact
G
+$21M
2
HLIO icon
Helios Technologies
HLIO
+$16.2M
3
MRC
MRC Global
MRC
+$14M
4
SLGN icon
Silgan Holdings
SLGN
+$12.6M
5
KNF icon
Knife River
KNF
+$12.2M

Sector Composition

Rank Sector Weight
1 Financials 20.58%
2 Industrials 20.29%
3 Healthcare 19.04%
4 Technology 11.95%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OVV icon
351
Ovintiv
OVV
$17.6B
$3.52M 0.07%
89,728
-204
-0.2% -$7.91K
HLX icon
352
Helix Energy Solutions
HLX
$1.49B
$3.51M 0.07%
559,666
+1,428
+0.3% +$9.49K
ENOV icon
353
Enovis
ENOV
$1.44B
$3.5M 0.07%
131,272
-41,847
-24% -$1.24M
DHR icon
354
Danaher
DHR
$146B
$3.49M 0.07%
15,259
-52
-0.3% -$11.4K
RNAM
355
DELISTED
Avidity Biosciences
RNAM
$3.48M 0.07%
48,288
+695
+1% +$44.9K
WAY
356
Waystar Holding Corp
WAY
$4.77B
$3.48M 0.07%
106,207
+559
+0.5% +$19.9K
PARK
357
Park Dental Partners
PARK
$94.8M
$3.48M 0.07%
+235,632
New +$3.23M
BDX icon
358
Becton Dickinson
BDX
$49.2B
$3.44M 0.07%
17,736
+27
+0.2% +$5.14K
BVS icon
359
Bioventus
BVS
$1.16B
$3.44M 0.07%
462,559
+980
+0.2% +$7.04K
IIIV icon
360
i3 Verticals
IIIV
$327M
$3.44M 0.07%
136,400
-845
-0.6% -$23.8K
DRS icon
361
Leonardo DRS
DRS
$11.9B
$3.42M 0.07%
100,366
+431
+0.4% +$15.9K
POWL icon
362
Powell Industries
POWL
$7.6B
$3.41M 0.07%
32,121
-29,256
-48% -$3.29M
COLB icon
363
Columbia Banking Systems
COLB
$8.96B
$3.34M 0.07%
119,358
+55,093
+86% +$1.49M
SGRY icon
364
Surgery Partners
SGRY
$1.98B
$3.33M 0.07%
215,705
+449
+0.2% +$8.25K
VECO icon
365
Veeco
VECO
$3.04B
$3.32M 0.07%
116,014
-708
-0.6% -$21K
ICLR icon
366
Icon
ICLR
$12.7B
$3.31M 0.07%
18,166
+4,958
+38% +$883K
INCY icon
367
Incyte
INCY
$24.6B
$3.3M 0.07%
33,440
+489
+1% +$47.3K
HROW icon
368
Harrow
HROW
$1.46B
$3.29M 0.07%
67,229
-416
-0.6% -$17.5K
KIDS icon
369
OrthoPediatrics
KIDS
$632M
$3.23M 0.07%
181,743
+16,230
+10% +$284K
ANNX icon
370
Annexon
ANNX
$868M
$3.21M 0.07%
639,902
-558
-0.1% -$2.13K
NTSK
371
Netskope Inc
NTSK
$6.15B
$3.16M 0.07%
+179,910
New +$3.75M
BMRC icon
372
Bank of Marin Bancorp
BMRC
$458M
$3.15M 0.07%
121,048
-753
-0.6% -$19.4K
MVBF icon
373
MVB Financial
MVBF
$393M
$3.12M 0.07%
+120,724
New +$3.2M
JRVR icon
374
James River Group Holdings
JRVR
$190M
$3.12M 0.07%
490,142
-436
-0.1% -$2.51K
WSR
375
DELISTED
Whitestone REIT
WSR
$3.08M 0.07%
221,402
-1,576
-0.7% -$20.3K

Similar funds

Kennedy Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Kennedy Capital Management held 594 positions worth $4.72B, up 4.4% from $4.52B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Kennedy Capital Management's Q4 2025 filing shows 39 new, 251 increased, 219 reduced and 63 closed positions. Its largest new stake was StandardAero Inc: 981,533 shares worth $28.2M. The largest sale was Genpact, an estimated $21M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

  • Kennedy Capital Management's largest Q4 2025 buy was StandardAero Inc: 981,533 shares worth $28.2M.
  • Kennedy Capital Management added most to Valmont Industries in Q4 2025, an estimated $21.6M increase.
  • Kennedy Capital Management's biggest Q4 2025 reduction was Helios Technologies, cutting an estimated $16.2M.
  • Kennedy Capital Management fully exited Genpact in Q4 2025, selling an estimated $21M.
  • Kennedy Capital Management's ten largest holdings make up 9.8% of its $4.72B portfolio in Q4 2025.
  • Kennedy Capital Management opened 39 new positions and closed 63 in Q4 2025.
  • Kennedy Capital Management's portfolio value rose 4.4% quarter-over-quarter to $4.72B.

Based on Kennedy Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.